for the PIRAD Study Group N osocomial infections and ventilator-acquired pneumonia (VAP) continue to be major causes of morbidity and mortality among patients hospitalized in intensive care units (ICUs) (1). These infections follow a sequence of previous colonization at the oropharyngeal level and subsequent infection occurring mainly by occult inhalation in the tracheobronchial tree (2-4). Oropharyngeal colonization by aerobic pathogens occurs very rapidly in ICU patients because of acquired changes in local antibacterial resistance, i.e., mucosal desiccation, decreased immunoglobin (Ig)-A salivary content, reduced salivary secretion, and mechanical injury induced by nasogastric and endotracheal tubes. Mucosal adhesion of aerobic bacilli is then facilitated and allows rapid bacterial growth on pharyngeal mucosa (5-6).
François Fourrier, MD, FCCM; Didier Dubois, MD; Philippe Pronnier, MD; Patrick Herbecq, MD; Olivier Leroy, MD; Thibaut Desmettre, MD; Elodie Pottier-Cau, MD; Hervé Boutigny, MD; Christophe Di Pompéo; Alain Durocher, MD; Micheline Roussel-Delvallez, MD; for the PIRAD Study Group N osocomial infections and ventilator-acquired pneumonia (VAP) continue to be major causes of morbidity and mortality among patients hospitalized in intensive care units (ICUs) (1) . These infections follow a sequence of previous colonization at the oropharyngeal level and subsequent infection occurring mainly by occult inhalation in the tracheobronchial tree (2) (3) (4) . Oropharyngeal colonization by aerobic pathogens occurs very rapidly in ICU patients because of acquired changes in local antibacterial resistance, i.e., mucosal desiccation, decreased immunoglobin (Ig)-A salivary content, reduced salivary secretion, and mechanical injury induced by nasogastric and endotracheal tubes. Mucosal adhesion of aerobic bacilli is then facilitated and allows rapid bacterial growth on pharyngeal mucosa (5) (6) .
The dental plaque is also involved in the sequence of initial colonization and represents an additional source of nosocomial colonization and infections in ICU patients. Dental plaque is a dynamic and complex system that associates microorganisms embedded in an extracellular matrix. It results from colonization and growth of aerobic, anaerobic, and filamentous microorganisms on the surfaces of teeth, soft tissues, and dental prostheses. Bacteria constitute approximately 70% to 80% of the solid material, and only 1 mm 3 of plaque contains at least 10 8 bacteria, including more than 300dif-ferent aerobic and anaerobic species. Dental plaque predominates on the subgingival and supragingival surfaces of the Objective: To document the effect of gingival and dental plaque antiseptic decontamination on the rate of nosocomial bacteremias and respiratory infections acquired in the intensive care unit (ICU).
Design: Prospective, multicenter, double-blind, placebo-controlled efficacy study.
Setting: Six ICUs: three in university hospitals and three in general hospitals.
Patients: A total of 228 nonedentulous patients requiring endotracheal intubation and mechanical ventilation, with an anticipated length of stay >5 days.
Interventions: Antiseptic decontamination of gingival and dental plaque with a 0.2% chlorhexidine gel or a placebo gel, three times a day, during the entire ICU stay.
Measurements and Main Results: Demographic and clinical characteristics, organ function data (Logistic Organ Dysfunction score), severity of condition (Simplified Acute Physiologic Score), and dental plaque status were assessed at baseline and until 28 days. Bacteriologic sampling of dental plaque and saliva was done every 5 days, and blood, tracheal aspirate, and bronchoalveolar lavage cultures were performed when appropriate. The primary efficacy end point was the incidence of bacteremia, bronchitis, and ventilatorassociated pneumonia, expressed as a percentage and per 1000 ICU days. All baseline characteristics were similar between the treated and the placebo groups. The incidence of nosocomial infections was 17.5% (13.2 per 1000 ICU days) in the placebo group and 18.4% (13.3 per 1000 ICU days) in the plaque antiseptic decontamination group (not significant). No difference was observed in the incidence of ventilator-associated pneumonia per ventilator or intubation days, mortality, length of stay, and care loads (secondary end points). On day 10, the number of positive dental plaque cultures was significantly lower in the treated group (29% vs. 66%; p < .05). Highly resistant Pseudomonas, Acinetobacter, and Enterobacter species identified in late-onset ventilator-associated pneumonia and previously cultured from dental plaque were not eradicated by the antiseptic decontamination. No side effect was reported.
Conclusions: Gingival and dental plaque antiseptic decontamination significantly decreased the oropharyngeal colonization by aerobic pathogens in ventilated patients. However, its efficacy was insufficient to reduce the incidence of respiratory infections due to multiresistant bacteria. (Crit Care Med 2005; 33:1728 -1735) KEY WORDS: nosocomial infection; ventilator-associated pneumonia; dental plaque; antiseptic decontamination; chlorhexidine; intensive care teeth, but without mechanical elimination it can cover the entire tooth surface (5) . Poor oral hygiene and lack of mechanical elimination are the main factors leading to proliferation and accumulation of dental plaque and subsequent colonization by aerobic pathogens (6) .
In a recent systematic review, Scannapieco et al. (7) identified 11 clinical studies demonstrating a significant association between periodontal disease and the occurrence of nosocomial infections. Elderly institutionalized, chronic obstructive pulmonary disease, and ICU patients are at higher risk of periodontal colonization by nosocomial pathogens because of difficulties in oral hygiene, changes in salivary properties, and reduction of anaerobic flora (8 -10) . These observations suggest that antiseptic decontamination could prevent or reduce oropharyngeal colonization by nosocomial pathogens and subsequent infections (11) . Four previously published studies addressed this issue in ICU patients (12) (13) (14) (15) . Genuit et al. (12) studied the effect of a prophylactic chlorhexidine oral rinse in 95 surgical ICU patients, compared with historical controls. They showed that the addition of oral care to a protocol of weaning from mechanical ventilation led to a significant reduction of late-onset VAP (12) . De Riso et al. (13) demonstrated in a doubleblind placebo-controlled study that a twice-daily 0.12% chlorhexidine oral rinse significantly decreased the incidence of total nosocomial respiratory infection and systemic antibiotic use in patients undergoing open heart surgery, with a 65% decrease (13% vs. 4%) in the overall nosocomial infection rate in the chlorhexidine group. In the same setting, Houston et al. (14) reported comparable results in an open comparative trial, with a 52% reduction in the prevalence of nosocomial pneumonia (4/270 patients in the chlorhexidine group vs. 9/291 in the placebo one). However, these studies included a population of postoperative patients, whose clinical baseline characteristics and risks of nosocomial infections are very different from those of a medical ICU population.
In a preliminary prospective opencontrolled study, we tried to document the effect of dental plaque antiseptic decontamination (PAD) in critically ill ventilated patients. We observed a reduction of the infection rate (53% relative risk reduction; odds ratio, 0.27; 95% confidence interval, 0.09 -0.80), with a trend toward reduction of mortality, length of stay, and duration of mechanical ventilation (15) .
These results argue the case for a multicenter double-blind placebo-controlled trial designed to document the effect of antiseptic decontamination of dental plaque on nosocomial infections. We report here the main clinical and bacteriologic results of this study.
DESIGN, METHODS, AND PATIENTS
Study Design. Eligible patients were enrolled in the trial from January 2001 to September 2002. It was a randomized, doubleblind, placebo-controlled trial conducted in six French ICUs (three in university hospitals and three in general hospitals). The study was approved by the institutional scientific and ethics committee of our university hospital and by the national scientific committee of the French Ministry of Health.
Selection Criteria. During the study period, all patients admitted to the ICUs were eligible when they or their relatives gave written informed consent and if they fulfilled the following criteria: age Ͼ18 yrs and a medical condition suggesting an ICU stay of at least 5 days and the requirement of mechanical ventilation by orotracheal or nasotracheal intubation. Patients with a tracheostomy tube at inclusion were not included. Only patients hospitalized for Ͻ48 hrs before admission in the ICU could be included. Patients had to begin treatment within 24 hrs after randomization (day 0).
Patients fulfilling the following criteria were excluded from the study: completely edentulous; suffering from facial trauma; postsurgical and requiring specific oropharyngeal care; and known allergy to chlorhexidine.
Treatment Assignments. The patients were randomly assigned (1:1) to undergo antiseptic decontamination of gingival and dental plaque with a specific gel containing chlorhexidine (0.2%; Elugel, Inava Oral Care, Pierre Fabre Santé, Boulogne, France) or a placebo gel. Block randomization stratified by site was used. Each patient received a randomization number, corresponding to an individual box containing four toothpaste tubes of gel, allowing the longest duration of treatment (28 days). The antiseptic gel and placebo gel were provided by Inava Oral Care. They were completely undistinguishable by color, taste, or odor. The investigators were unaware of patients' assignments; all randomization lists were held in sealed envelopes in the pharmacy departments of the six centers. The nursing team in each ICU was previously trained by the two odontologists involved in the study to ensure proper application of the gel and compliance to the protocol. After mouth-rinsing and oropharyngeal aspiration, the gel was applied directly by the nurses over the dental and gingival surfaces of the patient, with a sterile glove-protected finger. The gel was left in place and the oral cavity was not rinsed until the next application. It was applied at least three times a day during the entire ICU stay, until day 28. Patients were allowed to drink or eat freely according to their own ability and medical condition. Toothbrushing was not allowed in the protocol.
Evaluation of Patients. Patients were followed for 28 days after inclusion or until discharge or death. Baseline characteristics recorded included standard demographic information, medical history, reasons for ICU admission, respiratory failure, and ventilatory support. Severity of condition was assessed by measurement of the Simplified Acute Physiologic Score (SAPS) II (16) . The Omega score was used as measurement of the medical and nursing care loads (17) . This score, officially used in France, takes into account all the diagnostic and therapeutic procedures performed throughout the ICU stay, each one being given a definite number of points. The Omega 1 score refers to procedures performed once during the ICU stay. The Omega 2 score refers to procedures that could be repeated during the stay (for instance, one intermittent hemodialysis procedure scores 10 points). The Omega 3 score refers to procedures performed continuously throughout the day (for instance, every day of mechanical ventilation or continuous hemofiltration scores 10 points). The total Omega score is the sum of all Omega points. The Omega-day score refers to the sum of all Omega points divided by the number of days in the ICU. Organ dysfunctions were assessed by the Logistic Organ Dysfunction score (18) . Patients were intubated via the oral or nasal route, according to their clinical status and the habits of the physicians in charge. The modalities of mechanical ventilation and weaning were not dictated by the protocol. Anti-H 2 medications were not used.
Dental status was assessed by the CariesAbsent-Occluded (CAO) dental index described by Klein and Palmer (19) . This score is recommended by the World Health Organization and the International Dental Federation to measure dental status (20) . It is calculated as the sum of the Caried, Absent, and Occluded teeth and could range from 0 (normal dental status) to 28 (all teeth absent or decayed). In our study, a tooth was considered decayed when there was decay at least in the superficial enamel (dental classification S1). The amount of dental plaque was assessed by a score modified from the semiquantitative plaque index described by Silness and Loe (21) . The amount of plaque was scored from 0 to 3: 0 when the tooth surface looked clean, 1 when it looked clean and supragingival plaque could be removed from its gingival third with a sharp explorer, and 3 when it was covered by abundant deposits of plaque. Examination was done on the upper first premolars or, when these were missing, on the closest remaining teeth. Because of difficulties in the oral examination of these intubated patients, the assessment of dental plaque could not be done on all teeth and a single score was given for each patient, representing the score of the tooth with the greatest amount of plaque. This assessment of dental status was done on day 0 at each site by the same investigators who were previously trained by the two odontologists participating in the study (E. C. and H. B.). Before the study, the scores given by the investigators and the odontologists were compared in a series of at least ten patients in each ICU. Discrepancies were explained and discussed until there was good agreement for scoring. In addition, each center participating in the study was free to call via hotline one of the odontologists when difficulties arose.
Microbiology
Plaque for bacterial culture was sampled from the same teeth on days 0, 5, and 10 and every week if the patient was still in the ICU. To avoid false-negative results, the sampling was done at 8:00 am, just before application of the gel. The tooth surface was first carefully dried with a sterile gauze to avoid contamination by saliva. Samples of supragingival plaque were collected from the gingival third tooth surface with sterile absorbent paper points (Mynol Block Professional Dental Products, Jersey City, NJ). Each paper point was immersed in 1 mL of Ringer's solution. The sample was immediately transported to the laboratory, vortexed for 3 mins, and serially diluted in sterile saline. All dilutions were plated on blood-enriched agar with and without nalidixic acid, purple bromo-cresol, and heated blood with bacitracin and then aerobically cultured at 37°C for 72 hrs. All colonies were subcultured and identified by standard methods. Susceptibility tests were done in semiliquid medium (API ATB, bioMérieux, Marcy l'Etoile, France). Plaque culture was considered positive when it yielded Ն10 3 colony-forming units (CFU)/mL of Ringer's solution. These procedures aimed only to identify aerobic and facultative bacteria and fungi. Dental plaque colonization by anaerobic bacteria was not assessed. To document the effect of decontamination on oropharyngeal colonization, sequential salivary samples were drawn on days 0, 5, and 10. During the study, physicians in charge and investigators were unaware of the results of bacteriologic cultures of dental plaque and saliva. Blood, tracheal aspirate, and bronchoalveolar lavage cultures were performed during the stay if bronchitis, bacteremia, or VAP was suspected by the physician in charge. Prophylactic and antibiotic policy in the six ICUs included written procedures involving antibiotherapy and no selective digestive decontamination.
Definitions
The bacteriologic data for all patients and the medical records and files of the patients who developed a nosocomial infection were systematically reviewed before the allocation code was broken, and the diagnosis was considered definite when the following criteria were fulfilled. Colonization was defined as the isolation of microorganisms from dental plaque, saliva, and tracheal aspirate, without signs of clinical infection. An infection was considered present at admission in the ICU when all criteria were fulfilled at admission or within 2 days. An infection was considered nosocomial and acquired in the ICU if the clinical condition fulfilling the criteria developed after the patient was in the ICU for 2 days or up to 5 days after discharge. The diagnosis of bacteremia was established when body temperature was Ͼ38°C or Ͻ36°C and one aerobic or anaerobic blood culture was positive. Two positive blood cultures were required for diagnosis of infection with coagulase-negative staphylococci. The diagnosis of nosocomial pneumonia was established with the following criteria: temperature Ͼ38°C or Ͻ36°C; presence of new infiltrates on chest radiographs; leukocytosis (Ͼ10 ϫ 10 3 /mm 3 ) or leukopenia (Ͻ3 ϫ 10 3 /mm 3 ); positive quantitative culture of tracheal aspirate (Ն10 6 CFU/mL) and/or positive culture of bronchoalveolar lavage fluid (Ն10 4 CFU/mL). The diagnosis of nosocomial bronchitis was considered with the following criteria: temperature Ͼ38°C; absence of infiltrates on chest radiographs; purulent sputum in tracheal aspirate; and positive quantitative culture (Ͼ10 5 CFU/mL) of tracheal aspirate. Bacterial strains isolated from blood, dental plaque, saliva, tracheal aspirate, and bronchoalveolar lavage fluid were considered identical when their susceptibilities to all tested antimicrobial agents were similar. Catheter colonization and urinary and softtissue infections were not studied in the trial.
Statistical Analysis
The effect of dental PAD was studied in intention-to-treat analysis. The primary efficacy end point was the incidence of nosocomial bacteremia, bronchitis, and VAP acquired in the ICU, calculated in each group as the sum of these three infections and expressed in percentage and per 1000 ICU days. This composite end point was chosen because we could observe in our preliminary studies a significant link between dental plaque colonization and nosocomial bacteremia as well as lung infection (15) .
The secondary end points were as follows:
• The incidence of VAP and bronchitis per 1000 days of mechanical ventilation and 1000 days of intubation;
• The incidence of VAP per 1000 days of mechanical ventilation and 1000 days of intubation; • The mortality in the ICU and the length of stay; and • The total Omega score and Omega-day score.
According to the results of our preliminary study and a median 30% incidence of nosocomial infections in the six participating ICUs, the trial was designed to test an incidence equal to 30% in the placebo group, vs. an incidence equal to 15% in the treated group. With ␣ ϭ 0.025 (interim analysis) and ␤ ϭ 0.10 on bilateral hypothesis, the study was planned to enroll 212 patients per group. An independent interim analysis was planned after enrollment of 212 patients with the following predetermined rules. We planned to stop the enrollment if a significant difference in the incidence of nosocomial infection was observed between the two groups, with p Ͻ 0.025. If the difference was not significant, we decided to test a ⌬-equivalence between the two groups, with ⌬ fixed to 0.10 (commonly used for testing equivalence of frequencies). We planned to stop the enrollment if the ⌬-equivalence was assessed. The interim analysis was done in September 2002, and the difference between the two groups was not significant (chi-square ϭ 0.0297; p ϭ .86). Difference between incidence rates was estimated as 0.0088 (95% confidence interval, Ϫ0.091 to 0.0109). According to the rules, the study was stopped at the end of September 2002.
Data were analyzed according to a prospectively defined plan. Intergroup comparisons of baseline characteristics were made with analysis of variance, Student's t-test, or the chisquare test when appropriate. The crude incidences were compared by the chi-square test. Incidence densities were compared by computation of the relative risk between the two groups (relative risk, 0.99; 95% confidence interval, 0.52-1.85) (22) . The intervals from inclusion to first nosocomial infection, death, or discharge were compared in the two groups by the Kaplan-Meier method, and differences were assessed with the log-rank test. Results are given as mean Ϯ SD. All p values are two-sided. Statistical significance was considered at p Ͻ .05.
RESULTS

Patients and Baseline Characteristics.
Overall, 228 patients were enrolled in the study and randomized (114 in the PAD group and 114 in the placebo group). All randomized patients received the PAD or the placebo. One patient was secondarily excluded because oral topical antibiotherapy was needed. All patients were fol-lowed until 28 days in the ICU, death, or discharge (Fig. 1) . The numbers of patients included in the six centers were 58, 10, 33, 5, 65, and 57. There was no significant difference in the patients' baseline characteristics between the centers.
At baseline, the demographic characteristics, preexisting medical conditions, underlying diseases, and severity of diseases were similar between the two groups ( Table 1) . The modalities and routes of intubation and mechanical ventilation were not significantly different. Two-thirds of the patients were considered infected at admission to the ICU by the physicians in charge. These infections mainly involved exacerbation of chronic bronchitis in chronic obstructive pulmonary disease and community-acquired pneumonia with acute respiratory failure. The mean Simplified Acute Physiologic Score and Logistic Organ Dysfunction score were consistent with a selected population of critically ill patients, with a high frequency of organ failures.
Dental plaque baseline characteristics were also similar between both groups ( Table 2 ). The mean Caries-AbsentOccluded score was consistent with the usual dental status of the French population at the same age (23) . The dental plaque score on day 0 was very high, with 90% of patients having a score Ն2, consistent with a low level of oral care. Dental plaque culture was positive at admission for about 50% of patients, and in one-third of these patients aerobic pathogens (mainly Gram-negative) were noted. Dental plaques were more frequently colonized by Candida albicans in the placebo group (21% vs. 12%; p Ͻ .05), but the baseline prevalence of aerobic pathogens did not differ between the two groups.
Efficacy of PAD on the Incidence of Nosocomial Infection. Main results are shown in Table 3 . Twenty patients (17.5%) in the placebo group and 21 (18.4%) in the PAD group acquired bacteremia, VAP, or bronchitis during their ICU stay (not significant). The incidence of nosocomial bacteremia and VAP per 1000 ICU days was nearly identical between the PAD group and the placebo group. A higher number of occurrences of bronchitis was observed in the placebo group; the number of occurrences of bacteremia was higher in the PAD group, but these differences were not significant. Concerning the secondary end points, no difference was observed in the incidence of VAP per ventilator or intubation days, mortality, length of stay, or care loads. There was no difference in the times from inclusion to first nosocomial infection (Fig. 2) , death, or discharge (data not shown). The types of nosocomial infection and the microorganisms isolated from the infectious site and from dental plaque are reported in Table 4 . Gramnegative multiresistant rods accounted for the majority of VAP episodes, whereas staphylococci were identified mainly in cases of bacteremia. Except in one case, bacteria isolated from dental plaque and blood cultures were not identical. On the contrary, there was a high level of concordance between bacteria isolated from plaque and those from the lung. At inclusion, four patients in the control group were already colonized by the bacteria subsequently identified in the early VAP episodes and four patients in the PAD group. After day 8, among episodes of late-onset respiratory infection, eight (67%) of 12 in the placebo group and six (67%) of nine in the PAD group were preceded by dental plaque colonization with the same bacteria. These infections were mostly due to highly resistant pathogens; Pseudomonas aeruginosa, Acinetobacter baumannii, and Enterobacter species were the most frequent isolates.
Efficacy of PAD on Colonization. The effects of PAD on dental plaque colonization are shown in Table 5 . Because of early discharge (n ϭ 83), death (n ϭ 30), or technical difficulties, sequential dental plaque samples could be obtained from 137 patients on day 5 and 66 patients on day 10. Among the 137 patients who underwent plaque sampling on day 0 and day 5, the incidence of dental plaque colonization was not different between the placebo group and the treated one at baseline; a lower number of plaque samples remained negative or became negative on day 5 in the treated group, but the difference was not statistically significant. When considering only the 66 patients who underwent a plaque sampling on days 0, 5, and 10, we found no significant difference in baseline characteristics, but the number of samples remaining positive on day 10 was significantly lower in the treated group, with 29% of cultures positive vs. 66% in the placebo group (p Ͻ .05). There was close concordance between the aerobic pathogens isolated from dental plaque and from saliva. Dental plaque and saliva cultures yielded identical results at the same times in 81.2% of cases. In 13% of cases, saliva culture was positive and dental plaque culture was negative, whereas saliva culture was negative and dental plaque culture was positive in 5.2%.
DISCUSSION
The possibility that the colonization of dental plaque could play a significant role in the occurrence of respiratory nosocomial infections in ICU ventilated patients is supported by several studies (7, 8, 10) . Sequential sampling of dental plaque from ICU patients has shown that usually Ͼ50% of patients acquiring a respiratory infection are previously colonized at the gingivodental level by the same pathogens. The causative role of this colonization is supported by a recent study by El-Sohl et al. (10) , who demonstrated that in critically ill elderly patients respiratory pathogens isolated from dental plaque genetically matched those recovered from bronchoalveolar fluid (10). Consequently, teeth should be considered a substantial reservoir of respiratory pathogens, whose decontamination could reduce the incidence of acquired respiratory infections. However, in the present study the antiseptic chlorhexidine decontamination did not reduce the incidence of nosocomial infections, and there was no significant difference in any of the primary or secondary end points of the study. How could this negative result be explained?
Our study entails some clear limitations and biases. Contrasting with the 30% incidence of nosocomial infections anticipated in the control group, a mean incidence of 18% was actually observed in the study. With such an incidence of nosocomial infections in the control group, the number of patients enrolled in the trial was insufficient to document a significant effect of the decontamination protocol. This low rate of infections might be linked to a potential "study" effect (due to the application of a strict independent nosocomial survey and careful review) and/or mostly to the selection criteria determined for the trial, which excluded both the less and the more severe patients. Despite these limitations, the possibility that the decontamination procedure could have a significant global efficacy seems unlikely. Indeed, there was strictly no difference and no trend toward difference for any of the end points of the study between the placebo and the study group.
Contrasting with these results, the analysis of bacteriologic data showed that the decontaminating procedure substantially reduced the development of dental colonization during the ICU stay. When analyzing only the patients who underwent sequential dental sampling, we noted that the frequency of dental colonization increased during the ICU stay in the placebo group (64% positive cultures on day 5 and 81% on day 10), whereas it remained stable in the treated group (53% on day 5 and 56% on day 10). In the treated group, 29% of the dental plaque specimens positive at admission remained positive on day 10, compared with 66% in the control group. These results were consistent in terms of the significant effect of the decontamination at the gingivodental level, although it was obviously unable to eradicate the more resistant bacteria. In the vast majority of cases, the late-onset respiratory infections observed in both groups were due to P. aeruginosa, A. baumannii, and Enterobacter species, and these infections mostly were preceded by dental plaque colonization by the same pathogens, with a very significant concordance between the isolated strains.
Our previous studies and the present one suggest that dental plaque and saliva form a common bacterial reservoir, although it is impossible to document which one is the first to be colonized during the ICU stay. The diffusion of the chlorhexidine gel in saliva and in oropharyngeal mucosa remains unknown, as does its potential action at the gastric level after swallowing, and consequently these reservoirs could have had a significant role in the occurrence of the acquired infections.
A complete lack of activity of the chlorhexidine gel seems unlikely. Previously published studies have shown that the gel we chose for our study has powerful bactericidal properties against aerobic pathogens and fungi in vitro and efficiently prevents the formation and growth of dental plaque in dental clinic outpatients. We decided to use the gel instead of simple mouth-rinsing to take advantage of its high adhesive property and long-lasting action on oropharyngeal mucosa and dental surfaces. This is why it is widely used in cancer patients to prevent gingival infections and dental caries after local radiotherapy or bone marrow transplantation (11, 24) . Concerning its effects on nosocomial pathogens, we verified before our study whether in vitro the gel exhibited an antiseptic bactericidal activity on the more antibiotic-resistant strains encountered in the ICU environment (methicillin-resistant Streptococcus aureus, Klebsiella pneumoniae, A. baumannii, P. aeruginosa). Compared with control tubes containing the diluted bacterial culture and Müller-Hinton broth, in which the mean bacterial concentration increased from 1.10 5 to 2.10 9 in 24 hrs, no bacterial growth could be detected at any time in chlorhexidine tubes containing the 0.2% chlorhexidine gel (15) . Contrasting with these data, the decontaminating protocol was obviously unable to completely eradicate these bacteria from dental plaque and the oropharynx. An acquired resistance of nosocomial pathogens to the chlorhexidine gel might account for this lack of effect. Recent studies have shown that the susceptibility of Gram-negative bacteria to chlorhexidine can be reduced (25, 26) ; a considerable increase in the antiseptic concentration is required to induce a bactericidal effect (24) . Moreover, an association between intensity of chlorhexidine use and the reduced susceptibility of aerobic pathogens has been recently reported (27, 28) . In our study, the lack of eradication could also be linked to the inability of the antiseptic gel to reach the bacteria embedded in dental plaque and pharyngeal mucosa, owing to the formation of an oral biofilm. Clinical studies involving critically ill patients have shown that inadequate salivary flow and xerostomia promote the development of pharyngeal mucositis and colonization by aerobic pathogens (9) . The presence of endotracheal or feeding tubes and multiple additional individual factors contribute to the formation of a biofilm deeply resistant to antiseptics or antibiotics. Because of complex regulation of growth, cell-cell communication, and genetic factors, P. aeruginosa, A. baumannii, and Enterobacter species are particularly a concern in that process (29, 30) . In our study, the insufficient concentration of the antiseptic gel, combined with the lack of mechanical elimination, could explain the incomplete eradication of the aerobic pathogens embedded in the dental plaque and pharyngeal mucosa. This hypothesis might explain the discrepancies between our results and the favorable effects of preventive antiseptic decontamination in less severely ill patients undergoing planned cardiac surgery (13, 14) or the efficacy of selective digestive decontamination regimens combining oropharyngeal decontamination via an antibiotic oral paste with systemic antibiotherapy (31, 32) .
We conclude from our study that gingival and dental PAD decreases the rate of plaque colonization by aerobic pathogens in ventilated patients. However, this effect is insufficient in more critically ill patients, and the decontamination does not reduce the incidence of nosocomial bacteremia and respiratory infections due to multiresistant bacteria. It remains to be documented whether antiseptic decontamination of the dental plaque combined with oropharyngeal and salivary decontamination can decrease the rate of nosocomial infections in these patients. sité de Lille II, France). They also thank all the nurses of the intensive care units and the technical staffs of the microbiology laboratories and pharmacy departments who participated in the study.
